Pharmacological advantages of melatonin in immunosenescence by improving activity of T lymphocytes

Abstract

Melatonin plays a critical role in regulating photoperiodic signals and has recently been shown to decrease immunosenescence with age. In this study, we examined whether melatonin activates T lymphocytes as major adaptive immune cells in in vitro and in vivo models. Splenocytes, CD4⁺, and naïve CD4 T lymphocytes were isolated from the spleen of BALB/c mice and the cell population patterns and mRNA profiles associated with T cell activation (CD28 and p21) and the melatonin receptor (MT1A and MT1B) were assessed. The T cell activation-related proteins Ki67 and Bcl2 were also evaluated to confirm the relationship between gene and protein levels. Our data clearly revealed that CD28, p21, MT1A, and MT1B mRNA were highly expressed in the presence of melatonin. Co-culture of CD4⁺ T lymphocyte and peritoneal macrophage 7 days after melatonin administration to young and aged mice significantly increased APRIL mRNA, suggesting induction or maintenance of T lymphocyte responses. We also found that the intracellular amount of Ki67 and Bcl2 proteins were significantly upregulated in aged CD4⁺ T lymphocytes, suggesting enhancing T cell proliferation and ling-term maintenance of memory T cells. Taken together, we conclude that melatonin supplementation may enhance immunity in aged individuals by upregulating immunosenescence indices in association with T lymphocytes and may be an attractive pharmacological candidate for aged and immunocompromised individuals.

Keywords

melatonin / aging / CD4⁺ / naïve CD4 / melatonin receptor

References

[1] Reiter RJ. The melatonin rhythm: both a clock and a calendar[J]. Experientia, 1993, 49(8): 654–664.

[2] Pires ML. Benedito-Silva AA, Pinto L, Acute effects of low doses of melatonin on the sleep of young healthy subjects[J]. J Pineal Res, 2001, 31(4): 326–332

[3] Mundey K, Benloucif S, Harsanyi K, Phase-dependent treatment of delayed sleep phase syndrome with melatonin[J]. Sleep, 2005, 28(10): 1271–1278.

[4] Korkmaz A, Topal T, Tan DX, Role of melatonin in metabolic regulation[J]. Rev Endocr Metab Disord, 2009, 10(4): 261–270.

[5] Tan DX, Manchester LC, Terron MP, One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?[J]. J Pineal Res, 2007, 42(1): 28–42.

[6] Peyrot F, Ducrocq C. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species[J]. J Pineal Res, 2008, 45(3): 235–246.

[7] Jaworek J. Nawrot-Porabka K, Leja-Szpak A, Melatonin as modulator of pancreatic enzyme secretion and pancreatoprotector[J]. J PhysiolPharmacol, 2007, 58(Suppl 6): 65–80

[8] Bubenik GA. Gastrointestinal melatonin: localization, function, and clinical relevance[J]. Dig Dis Sci, 2002, 47(10): 2336–2348.

[9] Fischer TW, Slominski A, Zmijewski MA, Melatonin as a major skin protectant: from free radical scavenging to DNA damage repair[J]. Exp Dermatol, 2008, 17(9): 713–730.

[10] Zjacić-Rotkvić V. Kavur L, Cigrovski-Berković M. Hormones and aging[J]. Acta Clin Croat, 2010, 49(4): 549–554.

[11] Touitou Y. Human aging and melatonin. Clinical relevance[J]. Exp Gerontol, 2001, 36(7): 1083–1100.

[12] Currier NL, Sun LZ, Miller SC. Exogenous melatonin: quantitative enhancement in vivo of cells mediating non-specific immunity[J]. J Neuroimmunol, 2000, 104(2): 101–108.

[13] Caroleo MC, Doria G, Nisticò G. Melatonin restores immunodepression in aged and cyclophosphamide-treated mice[J]. Ann N Y Acad Sci, 1994, 719: 343–352.

[14] Srinivasan V, Maestroni GJ, Cardinali DP, Melatonin, immune function and aging[J]. Immun Ageing, 2005, 2: 17.

[15] Pawelec G, Akbar A, Caruso C, Is immunosenescence infectious?[J]. Trends Immunol, 2004, 25(8): 406–410.

[16] Hawkley LC, Cacioppo JT. Stress and the aging immune system[J]. Brain Behav Immun, 2004, 18(2): 114–119.

[17] Yeleswaram K. McLaughlin LG, Knipe JO, Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications[J]. J Pineal Res, 1997, 22(1): 45–51

[18] Sánchez-Hidalgo M. Guerrero Montávez JM, Carrascosa-Salmoral Mdel P, Decreased MT1 and MT2 melatonin receptor expression in extrapineal tissues of the rat during physiological aging[J]. J Pineal Res, 2009, 46(1): 29–35

[19] Stein JV. López-Fraga M, Elustondo FA, APRIL modulates B and T cell immunity[J]. J Clin Invest, 2002, 109(12): 1587–1598

[20] Soares A, Govender L, Hughes J, Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation[J]. J Immunol Methods, 2010, 362(1-2): 43–50.

[21] Grayson JM, Zajac AJ, Altman JD, Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells[J]. J Immunol, 2000, 164(8): 3950–3954.

[22] Haynes L, Maue AC. Effects of aging on T cell function[J]. Curr Opin Immunol, 2009, 21(4): 414–417.

[23] Deeks SG. HIV infection, inflammation, immunosenescence, and aging[J]. Annu Rev Med, 2011, 62: 141–155.

[24] Fagnoni FF, Vescovini R, Passeri G, Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging[J]. Blood, 2000, 95(9): 2860–2868.

[25] Calvo JR. Rafii-el-Idrissi M, Pozo D, Immunomodulatory role of melatonin: specific binding sites in human and rodent lymphoid cells[J]. J Pineal Res, 1995, 18(3): 119–126

[26] Carrillo-Vico A, García-Pergañeda A, Naji L, Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system[J]. Cell Mol Life Sci, 2003, 60(10): 2272–2278

[27] Arias CF. Ballesteros-Tato A, García MI, p21CIP1/WAF1 controls proliferation of activated/memory T cells and affects homeostasis and memory T cell responses[J]. J Immunol, 2007, 178(4): 2296–2306

[28] Eddahri F, Denanglaire S, Bureau F, Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities[J]. Blood, 2009, 113(11): 2426–2433.

[29] Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown[J]. J Cell Physiol, 2000, 182(3): 311–322.

[30] Poon AM, Liu ZM, Pang CS, Evidence for a direct action of melatonin on the immune system[J] . Biol Signals, 1994, 3(2): 107–117.

Acknowledgement

This research was supported by High Value-added Food Technology Development Program, Ministry of Agriculture, Food and Rural Affairs (MAFRA; grant number 113034-3)

RIGHTS & PERMISSIONS

2016 2016 by the Journal of Biomedical Research. All rights reserved.